PortfoliosLab logo
MDT vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MDT and JNJ is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MDT vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medtronic plc (MDT) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MDT:

0.26

JNJ:

0.21

Sortino Ratio

MDT:

0.41

JNJ:

0.32

Omega Ratio

MDT:

1.05

JNJ:

1.04

Calmar Ratio

MDT:

0.11

JNJ:

0.16

Martin Ratio

MDT:

0.65

JNJ:

0.42

Ulcer Index

MDT:

6.54%

JNJ:

6.59%

Daily Std Dev

MDT:

21.72%

JNJ:

19.20%

Max Drawdown

MDT:

-57.63%

JNJ:

-52.60%

Current Drawdown

MDT:

-28.22%

JNJ:

-9.74%

Fundamentals

Market Cap

MDT:

$111.54B

JNJ:

$366.90B

EPS

MDT:

$3.28

JNJ:

$8.99

PE Ratio

MDT:

26.52

JNJ:

16.96

PEG Ratio

MDT:

1.49

JNJ:

1.03

PS Ratio

MDT:

3.36

JNJ:

4.11

PB Ratio

MDT:

2.24

JNJ:

4.66

Total Revenue (TTM)

MDT:

$24.61B

JNJ:

$89.33B

Gross Profit (TTM)

MDT:

$15.68B

JNJ:

$61.01B

EBITDA (TTM)

MDT:

$6.89B

JNJ:

$34.70B

Returns By Period

In the year-to-date period, MDT achieves a 8.98% return, which is significantly higher than JNJ's 7.10% return. Over the past 10 years, MDT has underperformed JNJ with an annualized return of 3.62%, while JNJ has yielded a comparatively higher 7.10% annualized return.


MDT

YTD

8.98%

1M

4.56%

6M

3.30%

1Y

5.65%

3Y*

-2.38%

5Y*

0.89%

10Y*

3.62%

JNJ

YTD

7.10%

1M

-2.42%

6M

2.05%

1Y

4.00%

3Y*

-1.74%

5Y*

3.80%

10Y*

7.10%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Medtronic plc

Johnson & Johnson

Risk-Adjusted Performance

MDT vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDT
The Risk-Adjusted Performance Rank of MDT is 5555
Overall Rank
The Sharpe Ratio Rank of MDT is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of MDT is 4848
Sortino Ratio Rank
The Omega Ratio Rank of MDT is 4949
Omega Ratio Rank
The Calmar Ratio Rank of MDT is 5757
Calmar Ratio Rank
The Martin Ratio Rank of MDT is 6060
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 5454
Overall Rank
The Sharpe Ratio Rank of JNJ is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 4646
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 4646
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 5959
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 5757
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MDT vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MDT Sharpe Ratio is 0.26, which is comparable to the JNJ Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of MDT and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

MDT vs. JNJ - Dividend Comparison

MDT's dividend yield for the trailing twelve months is around 3.24%, more than JNJ's 2.42% yield.


TTM20242023202220212020201920182017201620152014
MDT
Medtronic plc
3.24%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%1.66%
JNJ
Johnson & Johnson
2.42%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

MDT vs. JNJ - Drawdown Comparison

The maximum MDT drawdown since its inception was -57.63%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for MDT and JNJ. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MDT vs. JNJ - Volatility Comparison

The current volatility for Medtronic plc (MDT) is 5.50%, while Johnson & Johnson (JNJ) has a volatility of 6.05%. This indicates that MDT experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MDT vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Medtronic plc and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
8.29B
21.89B
(MDT) Total Revenue
(JNJ) Total Revenue
Values in USD except per share items

MDT vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Medtronic plc and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%62.0%64.0%66.0%68.0%70.0%JulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
66.5%
66.4%
(MDT) Gross Margin
(JNJ) Gross Margin
MDT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medtronic plc reported a gross profit of 5.51B and revenue of 8.29B. Therefore, the gross margin over that period was 66.5%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.

MDT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medtronic plc reported an operating income of 1.65B and revenue of 8.29B, resulting in an operating margin of 19.9%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.

MDT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medtronic plc reported a net income of 1.29B and revenue of 8.29B, resulting in a net margin of 15.6%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.